The fully virtual conference will focus on the theme of “Resilience in dementia: Moving beyond the COVID-19 pandemic”, and TauRx will present, 1st December, 1pm, on late-stage clinical trial conduct during COVID-19: challenges, lessons, and the future for Alzheimer’s disease management.
The symposium will be chaired by Dr Serge Gauthier, Director of the Alzheimer Disease and Related Disorders Research Unit of the McGill University Research Centre for Studies in Aging. Dr Sonya Miller, TauRx Head of Medical Affairs, Dr Linda Sommerlade, GT Diagnostics Head of Operations and Professor Bjoern Schelter, GT Diagnostics CEO will each present in this reflective and insightful symposium presentation.
Alzheimer Europe is a non-profit non-governmental organisation (NGO) aiming to provide a voice to people with dementia and their carers, make dementia a European priority, promote a rights-based approach to dementia, support dementia research and strengthen the European dementia movement.
Look out for the hashtag #31AEC on social media to promote the important conference.
